Correlating GLP-1 Outcomes with Advanced Lab Panels

Vibrant Wellness Presents

Correlating GLP-1 Outcomes with Advanced Lab Panels

Join us for an educational dinner and clinical discussion exploring how advanced laboratory testing can help clinicians better understand and optimize patient outcomes when using GLP-1 therapies.

During this presentation, Dr. Haad Mahmood will review how key biomarkers from the Foundation Zoomer can provide insight into metabolic health, immune activity, and insulin signaling. The discussion will highlight markers related to metabolic regulation, cytokine-driven inflammation, and insulin resistance, helping practitioners better understand the underlying drivers of metabolic dysfunction in patients undergoing GLP-1 therapy.

The presentation will also explore how hormonal balance influences metabolic health and treatment outcomes. Dr. Mahmood will connect these findings with the Hormone Zoomer, demonstrating why evaluating endocrine function alongside metabolic and inflammatory markers can provide a more complete picture when managing patients using GLP-1 medications.

Special guests from PNOÉ will also be present to discuss VO₂ metabolic testing, providing additional insight into metabolic performance and patient physiology.

This event is designed for physicians and healthcare practitioners interested in integrating advanced biomarker testing into their metabolic and weight management protocols.

Know what’s Happening Next — before everyone else does.

Get App

Host or Publisher Vibrant Wellness